Theravance Biopharma will share clinical insights on norepinephrine reuptake inhibitor ampreloxetine at AAS 2025
Theravance Biopharma, Inc announced that it will be participating at the 36th International Symposium on the Autonomic Nervous System, organized by the American Autonomic Society (AAS), taking place November 5-8, 2025, in Clearwater… read more.
